Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26F7UD6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,995
Award facts
- Contract value 100% obligated
- $12,994.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector pharmaceutical product on December 1, 2025, with a ceiling value of $12,994.64 and ultimate completion date of December 22, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award leverages AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to supply medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal contracts with the Defense Logistics Agency covering a broad spectrum of pharmaceutical products and medical supplies. The company's established relationship with DLA's Medical Supply Chain includes delivery of specialty medications, vaccines, auto-injectors, and other critical healthcare commodities across multiple therapeutic domains. This delivery order for Benlysta, a specialty biologic used for autoimmune conditions, exemplifies the contractor's capability to fulfill specialized pharmaceutical requirements for military and federal healthcare systems through firm fixed-price mechanisms.
Quick answers
Who was awarded contract SPE2DR26F7UD6?
SPE2DR26F7UD6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F7UD6 worth?
The government has obligated $12,995 on SPE2DR26F7UD6.
Is contract SPE2DR26F7UD6 an order under another contract?
Yes. SPE2DR26F7UD6 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UD6 competed?
The extent of competition for SPE2DR26F7UD6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award